US 10738313
Chimeric antigen receptors targeting B-cell maturation antigen
granted A61KA61K2039/505A61K48/00
Quick answer
US patent 10738313 (Chimeric antigen receptors targeting B-cell maturation antigen) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Aug 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Aug 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K2039/505, A61K48/00, A61P, A61P35/00